Kohlberg recaps CRO Worldwide Clinical Trials

TJC, which has been Worldwide’s sole investor since 2007, retains a meaningful minority equity stake in the CRO.

12 December 2023•1 min read
LinkedInXEmail
LinkedInXEmail

Related articles